Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial

Many animal studies have shown that oral administration of the nicotinamide adenine dinucleotide (NAD(+)) precursor nicotinamide mononucleotide (NMN) prevents the reduction of NAD(+) levels in organs and tissues, helping alleviate aging-related diseases. However, there are very few clinical reports...

Descripción completa

Detalles Bibliográficos
Autores principales: Katayoshi, Takeshi, Uehata, Sachi, Nakashima, Noe, Nakajo, Takahisa, Kitajima, Natsuko, Kageyama, Masakatsu, Tsuji-Naito, Kentaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935856/
https://www.ncbi.nlm.nih.gov/pubmed/36797393
http://dx.doi.org/10.1038/s41598-023-29787-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935856/
https://www.ncbi.nlm.nih.gov/pubmed/36797393
http://dx.doi.org/10.1038/s41598-023-29787-3

Ejemplares similares